Simple exercise program may shield breast cancer patients from nerve damage
NCT ID NCT04583124
First seen Nov 18, 2025 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This study tested whether a program of therapeutic exercise and relaxation techniques (called ATENTO) could prevent nerve damage (neurotoxicity) in women newly diagnosed with breast cancer. 42 women were split into two groups: one started the program before cancer treatment, the other during treatment. Researchers measured quality of life and cognitive function to see which timing worked best.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Granada
Granada, 18016, Spain
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
therapeutic exercise and vagal activation techniques
What this could lead to
If it works, this could point toward a simple, drug-free way to prevent nerve damage from cancer treatment, improving quality of life for breast cancer patients.
What could go wrong
This is a very small, early study with only 42 participants, so results may not apply to everyone. The intervention is not a treatment for cancer itself, only for side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.